Bullish on Square, How to Fix Facebook & Abbott Laboratories CEO Talks Health Tech

Our anchors start off the show with CNBC’s Mike Santoli as the market rallies this morning. Then, Jefferies Analyst Trevor Williams is here to talk why he is bullish on Square. Next, we have NZS Capital Co-Founder Brad Slingerlend to discuss some of his picks in cloud, social media and cybersecurity. Later, New York Times Tech Reporter Shira Ovide joins to share ideas from her latest column “How to Fix Facebook” as the company faces backlash from lawmakers and whistleblower Frances Haugen. Plus, Abbott Laboratories CEO Robert Ford joins to discuss the company and the health tech space at large. Then, CNBC’s Yasmin Khorram is here with an update on the Elizabeth Holmes trial. And later, CNBC’s Phil LeBeau previews Tesla’s annual shareholder meeting slated for later today.